Twenty-four female Beagle dogs, 7-8 months old, were assigned to 4 groups. Control, low-dosage, medium-dosage, and high-dosage groups were offered 0, 1, 2, and 4 mg of sodium arsenite per kilogram of body weight per day (mg/kg/day), respectively, in their feed (equivalent to 0.0, 33.4, 66.7, and 133.4 µg/g in feed). On day 59, the dosage was doubled for the rest of the experiment, which ended on day 183. In general, arsenic concentrations in tissues and body fluids reflected arsenic levels in feed. Arsenic caused a dose-related decrease in food intake. Statistically significant differences in blood, liver, and kidney arsenic were detected, in most cases, between the 2 higher dosage groups and controls. The greatest differences in arsenic concentrations between groups were present in urine and hair. Results indicate that urine and hair would be the most useful specimens for chemical analysis when attempting to confirm low-level dietary inorganic arsenic exposure or poisoning.
1, 2, or 4 mg of sodium arsenite (NaAsO 2 ) per kilogram of body weight in the feed daily (Table 1) . After 58 days, the dosage of all groups was doubled for the rest of the experiment to maintain continued arsenic intake.
Both control dogs and principals were offered 2.75% of their body weight of dry dog food a daily for the first 2 weeks then 3.00% for the rest of the experiment. Control feed contained <0.1 µg/g arsenic. Stainless steel feed and water bowls were used. Every morning, dry feed was weighed and mixed with an equal amount (w/w) of water containing the appropriate dose of dissolved sodium arsenite. The feed and water were mixed thoroughly to insure even distribution of arsenic. The feed soaked up the water so that there was no excess. The mixture was offered to each dog for 6-8 h. Each night, the unconsumed feed was weighed and recorded. Dogs had free choice tap water at all times. The tap water contained <0.01 µg/g of arsenic. Changes of body weights were determined weekly, and the amount of feed and arsenic was adjusted accordingly.
The dogs were housed individually in stainless steel cages. b Each unit consisted of 2 cages 1 above the other. The assignment of dogs to cages was random, except the bottom dog was always from the same group as the top dog. The dogs were observed at least 3 times each day, and the cages were cleaned daily.
The experiment was divided into 3 phases (I, IIa, and IIb) on the basis of time and groups for analysis of the data generated (Table 1) . Phase I involved all groups from weeks 1-8. In phase I, nominal dosages of sodium arsenite for control, low dosage, medium dosage, and high dosage were 0, 1, 2, and 4 mg/kg/day, respectively. Phase IIa consisted of all groups from weeks 9-17 at nominal dosages double that of phase I (0, 2, 4, and 8 mg/kg/day). Phase IIa was ended when the high-dosage group was terminated because they had lost approximately 20% of their original body weight. Phase IIb consisted of control, low-dosage, and mediumdosage groups from weeks 9-26 at 0, 2, and 4 mg/kg/day, respectively. In all phases, the actual arsenic dosages were calculated daily by multiplying the percent of offered feed consumed by the appropriate nominal dosage. At the feeding Table 1 . Nominal dosages and actual average daily arsenic conrate of 3% of body weight per day, the phase I nominal sumption (mg) in dogs offered sodium arsenite-contaminated feed. dosages were equivalent to 33.4, 66.7, and 133.4 µg sodium arsenite/g of dry feed for low-, medium-, and high-dosage groups, respectively.
Periodic blood and urine samples were taken from all dogs. Control, low-dosage, and medium-dosage groups were sampled on weeks 2, 7, 13, 19, and 26. The high-dosage groups was sampled on weeks 2, 7, 13, and 19. Because of the early termination of 2 dogs in the high-dosage group, these 2 dogs were sampled on week 15 and the remaining 4 dogs of the high-dosage group were sampled on week 19. Urine was collected by transabdominal cystocentesis; some attempts were unsuccessful because of empty bladders. Occasionally 2 days elapsed before an attempt was successful, therefore samples from different dogs were secured within a period of 2-3 days.
Paired hair samples from the ventral thorax and abdomen were secured from each dog before exposure to arsenic and at the time of euthanasia. Hair was washed in a 0.5% surfactant, c rinsed in distilled deionized water, ashed in a muffle furnace, and analyzed for arsenic.
Animals were euthanized with an overdose of pentobarbital. Liver and kidney samples were collected during postmortem examination. Tissues, body fluids, and uncontaminated feed were quantitated for arsenic by hydride atomic absorption spectroscopy d according to method previously described 9 . Arsenic could not be quantitated accurately below 0.1 µg/g. Any sample at or below this limit was assigned an arsenic value of 0.1 µg/g to facilitate statistical examination.
Urine was also analyzed for creatinine. Commercially prepared reagents" were used in creatinine determinations to produce a picrate-creatinine color producing complex, which was then measured by a spectrophotometer. f This method removes pseudocreatinine from the determination. Urine arsenic/urine creatinine ratios (UAs/UCr) were calculated to minimize the variation of urine arsenic values due to different specific gravity values.
A complete random design was used to compare the different treatment groups. Individual dogs were the experimental units. Analysis of variance was done using a computer-based system, and a linear model was used to analyze arsenic consumed. g Classes were group, week of test, and individual animal. Least significant differences (LSD) were arsenic was significantly higher than that of controls and low-dosage groups (P < 0.01). Medium-dosage group phase IIa blood was higher than that of controls (P < 0.01) Medium-dosage group blood arsenic concentration was greater than that of controls in phase IIb (P < 0.01).
Urine arsenic concentrations for all groups were statistically different from each other in phase I. Differences between the control and low-dosage group had P values <0.05. All other differences had P values <0.01. In phase IIa, urine arsenic of high-and medium-dosage groups was again higher than that of controls (P < 0.01). High-dosage group phase IIa urine arsenic concentration was higher than that of the lowdosage groups (P < 0.01). Phase IIb urine arsenic for medium-and low-dosage groups was higher than that of controls (P < 0.01).
Urine arsenic/urine creatinine ratios (UAs/UCr) are given in Table 3 . Phase I values for UAs/UCr in low-, medium-, and high-dosage groups were higher than those of control groups (P < 0.01). Values for highdosage groups were significantly higher than those of calculated from the experimental error of dogs within group. 8 low-and medium-dosage groups. In phase IIa, the con-Blood and urine values were analyzed via the dog means for respective phases without consideration of time, because there trol group UAs/UCr was lower than those of the high-, were limited samples taken per dog in each phase. medium-(P < 0.01), and low-dosage (0.01 < P < 0.05) groups. High-and medium-dosage group values
Results
were also higher than those of the low-dosage groups (P < 0.01 and 0.01 < P <0.05, respectively). Values Arsenic consumption was determined by the feed of all three groups in phase IIb were significantly difintake. 5 Average sodium arsenite consumptions over-ferent from each other (P < 0.01). all in phases I, IIa, and IIb (Table 1) were statistically Liver and kidney arsenic concentrations at postdifferent from one another (P < 0.01).
mortem (Table 4 ) are given on wet weight basis. Least Table 2 shows the blood and urine arsenic concen-significant differences between groups for both liver trations for all three phases of the experiment. Medi-and kidney were 0.47 (P < 0.05) and 0.64 (P < 0.01), urn-dosage group phase I blood arsenic concentration respectively. High-dosage group liver arsenic concenwas significantly different from that of controls (0.01 tration was significantly higher (P < 0.01) than that of < P < 0.05). In phase IIa, high-dosage group blood control and low-dosage groups. There was no signifi- Table 2 . Mean blood and urine arsenic concentrations (µg/g) of dogs exposed to dietary sodium arsenite in treatment phases I, IIa, and IIb. cant difference between medium-and high-dosage group liver arsenic concentrations.
Kidney arsenic concentrations at postmortem were significantly higher (P < 0.01) in high-and mediumdosage groups than in control and low-dosage groups ( Table 4 ). There was no significant difference between medium-and high-dosage groups.
Initial and final hair arsenic concentrations are given in Table 4 . There were no significant differences among groups prior to arsenic exposure. Least significant differences between groups in final hair analyses were 6.84 (P < 0.05) and 9.33 (P < 0.01). The medium-dosage group differed significantly from the control, low and high dosage groups (P < 0.01). High-dosage group values differed significantly from those of the control and medium groups (P < 0.01) and low-dosage group (P < 0.05).
Discussion
The significant elevation of blood arsenic for the medium-dosage group in phase I and lack of elevation in the high-dosage group was unexplained. In phases IIa and IIb, blood arsenic concentrations were higher in groups exposed to more arsenic. The blood arsenic concentrations were significantly elevated in arsenicexposed groups when compared with control animals. The greatest mean difference was only 0.19 µg/g, which would not be a large enough difference to be helpful in diagnosing a field case of arsenic poisoning. The limited accumulation of arsenic in the blood is due to rapid clearance of inorganic arsenic from blood. The Table 3 . Mean urine arsenic/urine creatinine ratios ([µg/g]/[mg/ dl]) of dogs exposed to dietary sodium arsenite in treatment phases I, IIa, and IIb.
half-life for elimination of this element from blood following intravenous injection is 90-120 minutes in the dog. 2 The arsenic concentration in the urine of controls was markedly lower than that of the exposed groups. Urine arsenic reflected differences in dietary arsenic exposure. Groups given a nominal dosage of 4 or 8 mg/kg/day had decreased feed intake and subsequent weight loss. 5 Groups with decreased food intake had an average urine arsenic concentration of ≥ 16.21 µg/g ( Table 2 ). The UAs/UCr ratios were better indicators of differences in arsenic intake among groups than were simple urine arsenic concentrations. For experimental purposes, this ratio is a useful tool, but diagnostically it would not add enough information to justify the effort or expense.
In most species, 40-70% of absorbed inorganic arsenic is excreted in the urine within 48 hours. 11 In dogs, 40-45% of injected inorganic arsenic was excreted in 100 minutes. 10 This rapid urinary excretion explains the low levels of arsenic in liver and kidney and limited difference of tissue arsenic levels among groups. Because of the kidney's important role in inorganic arsenic excretion, it was not surprising that arsenic concentration in kidney was higher than that in liver. Liver and kidney arsenic concentrations in the higher dosage groups were significantly higher than those of controls.
Hair is generally a good indicator of long-term dietary arsenic exposure. In this trial, hair arsenic concentration did not reflect dietary exposure as reliably as did urine arsenic (Tables 2, 4 ). There was a great Table 4 . Mean liver, kidney, and hair arsenic concentrations (µg/ g) in dogs exposed to dietary sodium arsenite variance in hair arsenic concentrations (0.22-10.6, 0.29-33.5, and 0.11-17.90 µg/g in low-, medium-, and high-dosage groups, respectively). The reason for this variation was not apparent. Medium-dosage group hair arsenic values were higher than those of the high-dosage group, possibly because of malnutrition accompanied by marked weight loss as a result of aversion to a diet high in arsenic. 5 Protein deficiency causes defective hair production and defective hair may accumulate arsenic differently than normal hair. 3 Blood arsenic assays are of little or no diagnostic value in cases of chronic arsenic toxicosis. Assays of urine are more likely to provide useful data; dogs with clinical arsenic poisoning had average urine arsenic concentrations of ≥ 16.21 µg/g. Although these values are close to those found in the subclinical arsenic toxicosis dogs, these concentrations in suspected arsenic poisoning cases would support a diagnosis, if other evidence is present; 30 µg/g arsenic in urine is firm evidence that a dog has been exposed to enough arsenic to cause toxicosis. Liver and kidney arsenic concentrations generally remain low due to rapid excretion. If concentration of approximately 1 µg/g is found in liver or kidney, it is not diagnostic; however, chronic arsenic toxicosis should be considered if the clinical signs are compatible. Normal background levels in liver and kidney are usually <0.5 µg/g. 6 Concentrations > 10 ppm in liver and kidney are considered diagnostic for arsenic toxicosis. 6 Chemical analysis of urine and hair can give valuable diagnostic data in cases of chronic arsenic poisoning.
The results of chemical analysis should support a diagnosis when the history and clinical signs are compatible with chronic arsenic poisoning.
